Interestingly enough, I believe Medicare is legally prohibited from engaging in national-scale negotiations with pharmaceutical companies for annual purchase contracts (volume discount purchases).

This is how the Canadian healthcare system drives down the price of pharmaceuticals. In the vast majority of cases, these are the identical brand name products available in Canada at a significantly lower price than they are sold in the USA for.